NIH funding over time and tests for significant change within- and between-groups. by Paige Noble (8918912)

Participants inclination toward gambling exhibited a significant increase as the reward magnitude and reward probability increased. by Yasuhiro Mochizuki (3308349)

Significant changes in taxa at discharge. by Arnon Gal (3150036)

NIH adjusted funding over time and tests for significant change within- and between-groups. by Paige Noble (8918912)

Network analysis of significantly changing proteins. by Tyler D. P. Goralski (7506845)

General addictive models demonstrate the relationship between systemic inflammatory biomarkers and anti-HCV. by Lu Han (151620)

Subjects:

Succinate and Sucnr1 levels were significantly increased. by Jiaqi Wang (369548)

Dengue virus infection significantly increases cellular fatty acid contents. by Li Xu (108702)

Subjects:

Delphinidin alters VEGF-A splicing to increase VEGF-A₁₆₅b and decrease total VEGF-A expression. by Megan Stevens (3964886)

Immunohistochemistry using anti-Iba-1 and GFAP antibodies. by Naoto Arimura (416442)

Subjects:

Increased or reduced ATGL-1 activity does not significantly change <i>N. parisii</i> growth. by Hala Tamim El Jarkass (16625309)

Subjects:

Overview of brain regions with significant Ketamine-induced increase in gamma-band power and aperiodic slope change. by Jessie Rademacher (21512686)

“…<p>Overview of brain regions with significant Ketamine-induced increase in gamma-band power and aperiodic slope change.…”

Significant changes in taxa at 30 days. by Arnon Gal (3150036)

Podocyte specific KO of FcRn results in a significant decrease in glomerular crescents 8 days after anti-GBM disease induction. by James F. Dylewski (9922380)

“…Podocyte-specific KO of FcRn results in a significant decrease in the number of crescents (a, p = 0.035).…”

Changes in the positive direction ratio as the time scale of the change direction increases. by Teruko Takada (13977607)

Metabolites with significant changes between the groups. by José C. Páez-Franco (9722870)

Choosing cardiotoxic drug concentrations that elicited a change in metabolism without a significant increase in cell death. by Bonnie V. Dougherty (8721621)

Output-potent activity increase significantly. by Chenguang Zhang (457185)

Anatomic locations exhibiting significant changes in AxD and RD. by Sewon Lim (21989785)

Subjects:

Number of patients with a significant increase or significant decrease between the baseline measurement (SCr-BL) and the creatinine measurement at emergency department presentation... by M. S. A. Niemantsverdriet (11886431)